ArticleACS omega2026
Interpretable Machine Learning Frameworks for QSAR Modeling: A Comparative Study of Classical Algorithms and Transformer-CNN Architectures.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Phosphodiesterase type 5A (PDE5A) inhibitors represent an important class of bioactive molecules with therapeutic relevance across cardiovascular, neurological, and oncological disorders. In this work, we develop an interpretable Quantitative Structure-Activity Relationship (QSAR) framework that integrates classical machine learning (ML) approaches with a hybrid deep learning architecture (Transformer-Convolutional Neural Network, Transformer-CNN) to model enzyme inhibition using a curated and diverse data set from ChEMBL. Multiple structural descriptors and fingerprint-based representations were evaluated using established ML algorithms, with fingerprint-driven models, particularly those employing FCFP4 features, achieving the highest predictive performance with Matthews Correlation Coefficients up to 0.783. Comparative analysis revealed that optimized classical ML models slightly outperform the Transformer-CNN approach for this data set. Model interpretability was explored through Shapley Additive Explanations (SHAP) analysis, similarity maps, and atom-wise relevance scores, providing mechanistic insights and highlighting the importance of molecular symmetry and topological features in determining inhibitory potency. To support practical deployment, the final models were implemented in a freely accessible web application built with Flask and Streamlit for rapid prediction of novel compounds' inhibitory potential. Overall, this work provides a transparent and reproducible QSAR workflow, clarifies the relative strengths of classical and deep learning approaches, and offers a practical tool to assist in the design of next-generation PDE5A inhibitors.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.